Skip to content

Clinical trials

Retinal Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Clear all

130 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20054
20062
20071
20081
20093
20103
20115
20122
20133
20143
20157
20164
20173
201811
201914
202012
202113
20225
202313
20248
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Active, not recruiting22
Terminated18
Unknown status15
Recruiting13
Enrolling by invitation4
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beacon Therapeutics7
Kodiak Sciences Inc7
Nanoscope Therapeutics Inc.7
Gyroscope Therapeutics Limited5
National Eye Institute (NEI)5
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts4
Novartis Pharmaceuticals4
Gemini Therapeutics, Inc.3
Retina Implant AG3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration130
Retinal Diseases62
Eye Diseases55
Macular Degeneration52
Retinitis Pigmentosa33
Retinal Dystrophies18
Vision Disorders17
Geographic Atrophy14
Eye Diseases, Hereditary13
Wet Macular Degeneration13

Trials

Showing 51 to 75 of 130. Each trial links to its page on Pharma Observatory.

30 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.